Table 3.

Quantification of immune cells (CD20+ B cells, CD4+ T cells, CD8+T cells, CD68+ Macrophages, and CD163+ TAMs) in our 304 glioma cases (WHO I–IV).

	WHO I (n = 13)		WHO II (n = 82)		WHO III (n = 76)		WHO IV (n = 133)		Total (n = 304)
	Median	IQR	Median	IQR	Median	IQR	Median	IQR	Median	IQR
CD20	0	0–0	0	0–0	0	0–0	0	0–1	0	0–0
CD4	1	0–5	0	0–1	0	0–2	0	0–4	0	0–2
CD8	0	0–8	0	0–2	0	0–2	0	0–2	0	0–2
CD68	11	3–24	22	9–35	24	14–36	35	20–55	32	14–44
CD163	5	2–19	5	3–17	17	7–30	38	23–54	28	6–40

IQR, interquartile range.